Rigidification of the a2 helix of an MHC class I molecule by a valine to proline mutation in position 165 does not prevent peptide-specific antigen presentation

Rigidification of the a2 helix of an MHC class I molecule by a valine to proline mutation in position 165 does not prevent peptide-specific antigen presentation

Plaksin, D.; Polakova, K.; Mage, M.G.

Journal of Immunology 159: 08-14

1997

ISSN/ISBN: 0022-1767

(PDF emailed within 1 workday: $29.90)

Accession: 018100231

Download citation: RIS BibTeX Text

Related references

Rigidification of the alpha2 helix of an MHC class I molecule by a valine to proline mutation in position 165 does not prevent peptide-specific antigen presentation. Journal of Immunology 159(9): 4408-4414, 1997

Rigidification of the alpha-2 helix by a valine to proline mutation in position 162 of an MHC class I molecule does not prevent peptide specific antigen presentation. Journal of Allergy and Clinical Immunology 99(1 Part 2): S9, 1997

Effect of a Tyr-to-His point-mutation at position 59 in the alpha-1 helix of the HLA-B27 class-I molecule on allospecific and virus-specific cytotoxic T-lymphocyte recognition. Scandinavian Journal of Rheumatology. Supplement 87: 36-43, 1990

Mutational analyses of the six peptide-binding pockets of HLA-A2 molecule in virus-specific and allo-specific CTL responses A system for the study of HIV peptide presentation by class I molecule. Journal of Cellular Biochemistry Suppl 1993(17 Part E): 82, 1993

A mutation in a MHC class II molecule can lead to cross presentation of peptide and lack of presentation to self. FASEB Journal 8(4-5): A992, 1994

Characterization of the Antigen Processing Machinery and Endogenous Peptide Presentation of a Bat MHC Class I Molecule. Journal of Immunology 196(11): 4468-4476, 2016

Most residues on the floor of the antigen binding site of the class I MHC molecule H-2Kd influence peptide presentation. International Immunology 4(8): 945-953, 1992

Mutation of the alpha 2 domain disulfide bridge of the class I molecule HLA-A*0201. Effect on maturation and peptide presentation. Human Immunology 39(4): 261-271, 1994

Expression of a single-chain HLA class I molecule in a human cell line: Presentation of exogenous peptide and processed antigen to cytotoxic T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 93(1): 236-240, 1996

The effect of co-expression costimulatory molecule CD80 on uptake of antigen peptide-MHC class I-GFP complex by specific T cells. International Journal of Oncology 30(6): 1389-1396, 2007

Distinct mechanisms of T-cell cytolysis are engaged by conformation-specific presentation of an HLA class II antigen peptide complex. Arthritis and Rheumatism 40(9 Suppl. ): S35, 1997

Proline-glutamic acid-proline-lysine peptide set as a specific antigen for the serological diagnosis of strangles. Veterinary Record 159(19): 629-632, 2006

Inhibition of class I and class II MHC-restricted antigen presentation by cytotoxic T lymphocytes specific for an exogenous antigen. Journal of Immunology 148(10): 3028-3033, 1992

The MHC class II-associated invariant chain: a molecule with multiple roles in MHC class II biosynthesis and antigen presentation to CD4+ T cells. Critical Reviews in Immunology 16(4): 359-379, 1996

Class II MHC/peptide complexes on T cell antigen-presenting cells: agonistic antigen recognition inhibits subsequent antigen presentation. Cellular Immunology 186(2): 111-120, 1998

< Previous

∧ Chapter

Next >

© 2022 EurekaMag OÜ, Sakala 7-2, 10141 Tallinn, Estonia, Tel: +372 69 91692
Registry code: , Legal Entity Identifier (LEI): 984500A2C1AE68HDA873
Privacy · Disclaimer · Terms · Contact · 浙ICP备10204677号-1